SCHEMBL28899703

SCHEMBL28899703

N=C(N)NC(=N)N(O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
F2 P00734 1/20 0.37
F10 P00742 1/20 0.37
F12 P00748 1/20 0.37
F7 P08709 1/20 0.37
F3 P13726 1/20 0.37
PKM P14618 1/20 0.37
BLM P54132 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34
C1S P09871 1/20 0.34
PRSS3 P35030 1/20 0.34
RECQL P46063 1/20 0.34
WDR5 P61964 1/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3058170 0.82 ALDH1A1 (0.48) ALDH1A1F2F10F12F7
SCHEMBL725723 0.78 ALDH1A1 (0.36) ALDH1A1F2F10F12F7
SCHEMBL1741633 0.78 LMNA (0.44) ALDH1A1KMT2AMEN1KDM4EPLAU
SCHEMBL28899661 0.78 ALDH1A1 (0.36) ALDH1A1F2F10F12F7
SCHEMBL836169 0.77 MEN1 (0.44) ALDH1A1F2F10F12F7
Hydrochloric Acid SCHEMBL28340528 0.77 LMNA (0.43) ALDH1A1BLMKMT2AMEN1PRSS1
Hydrochloric Acid SCHEMBL7199219 0.77 BLM (0.38) ALDH1A1F2F10F12F7
SCHEMBL10448622 0.77 MEN1 (0.44) ALDH1A1F2F10F12F7
SCHEMBL16908930 0.77 CRHBP (0.39) ALDH1A1KMT2AMEN1NPC1NPSR1
SCHEMBL28899636 0.76 MEN1 (0.42) ALDH1A1F2F10F12F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115414480-A Dianhydrogalactitol in combination with radiation for treatment of non-small cell lung cancer and glioblastoma multiforme 德玛医药 2022-12-02 CN disclosed